Assessment of cardiotoxicity of purine analogues in patients with lymphoproliferative neoplasms treated with chemotherapy
Journal Title: Postępy Nauk Medycznych - Year 2012, Vol 25, Issue 9
Abstract
<b>Introduction. </b>Purine analogues are chemotherapeutics widely used in treatment of lymphoproliferative neoplasms. Knowledge of their influence on cardio-vascular system is small. Contemporary methods give us an opportunity of reliable assessment of cardio-vascular system.<br><b>The aim </b>of the study was presentation of the results of our research on cardiotoxicity of purine analogues.<br><b>Material and methods.</b> 8 patients were observed in the Department of Hematology and Bone Marrow Transplantation. Age of patients ranged from 51 to 75 (median – 63 years). There were 7 men and 1 woman. They were treated with purine analogues because of chronic lymphocytic leukemia and hairy cell leukemia. Observation lasted for 3 cycles of chemotherapy. We performed physical examination with assessment of basic parameters of cardio-vascular system (blood pressure, heart rate, symptoms of cardiac failure such as: peripheral edema, lung examination, liver enlargement), ECG, ECHO (with assessment of systolic and diastolic function of left ventricle). We also performed biochemical assessments (troponin I and NT-proBNP). All assessments were performed before we started the treatment and after 3 cycles of chemotherapy.<br><b>Results.</b> We observed patients for 3 cycles of chemotherapy (3-4 months). We didn’t found any symptoms suggesting cardiotoxicity of purine analogues in physical examination, ECG, ECHO or troponin I assessments. Results of our research before and after chemotherapy didn’t differ fundamentally. 63% of patient had elevated NT-proBNP level.<br><b>Conclusions.</b> Purine analogues turned out to be safe as far as cardiotoxicity is concerned during lasting few months observation. NT-proBNP results need farther research. Because of wide indications to use of purine analogues farther research should be carried on. Methods of assessment of cardio-vascular system are easily accessible and can be performed in all centers treating neoplasms.
Authors and Affiliations
Włodzimierz Mendrek, Patrycja Zielińska, Sławomira Kyrcz-Krzemień, Ewa Szołtysik, Elżbieta Pietruszka
Keywords
Related Articles
- EP ID EP54535
- DOI -
- Views 138
- Downloads 0
Study on intra and intreobserver variability of prostate cancer grading
<b>Introduction.</b> Adenocarcinoma of the prostate is one of the most frequent cancer in man. Clinical stage and grade based on Gleason score scale are main circumstances according to which a...
Interventional treatment for type 2 diabetes
Obesity and type 2 diabetes are currently the most serious health problems in developedand developing countries. According to standards of treatment of diabetes, especially withobesity, weight reduction is an essential e...
Clinical genetics of prostate cancer
Epidemiologic research conducted over the last two decades has led us to believe that inherited factors play an important role in the etiology of prostate cancer, but the genes, which underlie the inherited susceptibilit...
Opieka paliatywna we współczesnej onkologii
Medycyna paliatywna może być postrzegana jako jedna z najmłodszych dynamicznie rozwijających się dziedzin onkologii. Początki współczesnej medycyny paliatywnej datowane są na lata 60. XX wieku i były związane z pracami C...
Assessment of platelet aggregation in clinical practice
Introduction. Platelet mediated thrombosis plays central role in pathogenesis of acute coronary syndromes (ACS). Employing the point-of-care (POC) VerifyNow assay allows for bedside monitoring of platelet aggregation in...